Cigna Corp (CI): Today's Featured Health Care Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Cigna ( CI) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 1.1%. By the end of trading, Cigna fell 59 cents (-1.1%) to $51.65 on average volume. Throughout the day, three million shares of Cigna exchanged hands as compared to its average daily volume of 2.2 million shares. The stock ranged in price between $51.62-$52.94 after having opened the day at $52.74 as compared to the previous trading day's close of $52.24. Other companies within the Health Care sector that declined today were: CombiMatrix Corporation ( CBMX), down 45.1%, OxiGene ( OXGN), down 21.4%, SciClone Pharmaceuticals ( SCLN), down 19.4%, and Palatin Technologies ( PTN), down 15.2%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

CIGNA Corporation, a health services organization, through its subsidiaries, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $15.14 billion and is part of the health services industry. The company has a P/E ratio of 9.8, below the S&P 500 P/E ratio of 17.7. Shares are up 24.4% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Cigna a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, increase in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, NABI Biopharmaceuticals ( NABI), up 495.4%, Kips Bay Medical ( KIPS), up 33%, Cytori Therapeutics ( CYTX), up 18.9%, and Sequenom ( SQNM), up 18.8%, were all gainers within the health care sector with Thermo Fisher Scientific ( TMO) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.
null

If you liked this article you might like

Healthcare Management Stocks Look Too Pricey for Activists

The Stock That Crashed 25% Overnight Has a Lesson to Teach Us: Market Recon